A US class action litigation, which since 2017 has been hanging over Novo Nordisk and its three former executives, Lars Rebien Sørensen, Jesper Brandgaard and Jakob Riis, now seems to have reached its conclusion, the company reports in a press release.
The company writes that an agreement to settle has been reached in the case concerning alleged violations of the US securities laws. The plaintiffs, shareholders of Novo Nordisk, claimed that the company and aforementioned executives were guilty of market manipulation back in 2015 and 2016, when company share price took a significant dip over a long period.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Drug Safety Associate 
Nordic Key Account Manager, Hollister & Dansac 
Scientist Radiochemistry 
Product specialist in Cardio Rhythm Management, Zealand 
Vice President, Medical Affairs 
Senior Manager, System Change & Release Management 
Pharmacovigilance & Regulatory Officer 
Clinical Project Lead 
Regulatory Project Manager 
Lab Manager 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Ambitious Business Relationship Manager for the Danish Medicines Agency 
Senior/lead consultant at Emendo Engineering 
Manager of QA, BHS Logistics 
Product specialist